January 5, 2024 07:02 AM ESTUpdated January 6, 03:34 AM
People
Peer Review

Evotec CEO Wern­er Lan­thaler re­signs; Af­ter No­vo deal, ex-For­ma chief ush­ers in new era at Paci­ra

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Wern­er Lan­thaler an­nounced his res­ig­na­tion as CEO of se­r­i­al Big Phar­ma part­ner Evotec on Wednes­day, and his for­mer COO Mario Poly­wka will fill in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times